Which Mycotoxin Test Best Represents Indoor Exposure?

Explore how air, dust, and surface mycotoxin testing differ and which method most accurately represents occupant exposure in indoor environments.

Who This Guide Is For

This guide is written for homeowners, Indoor Environmental Professionals, clinicians, consultants, and remediation specialists who need to determine which mycotoxin testing method best represents indoor occupant exposure for a specific environmental question.

It explains why air, dust, surface, and HVAC filter sampling methods operate within non-equivalent analytical domains, and why selecting a mycotoxin test without first defining the exposure pathway being evaluated often leads to misleading or contradictory results.

This guide does not establish health thresholds, medical diagnoses, regulatory standards, remediation requirements, or legal evidentiary criteria. It clarifies how to align test selection with exposure pathway and analytical domain constraints.

Comparison of air sampling, settled dust, and surface swab methods to illustrate which mycotoxin test best represents indoor exposure assessment

What This Guide Explains

This guide focuses on mycotoxin test selection, not post-test result interpretation.

It introduces a structured, exposure-aligned decision logic that begins with defining the hazard class and environmental question, and only then selects the appropriate analytical domain for sampling.

This framework explains why:

  • The same space can test “positive” by one method and “negative” by another
  • Dust or filter samples can show contamination when air samples do not
  • Air samples can show inhalation-relevant chemical signals when little appears on surfaces

These outcomes are not contradictions. They result from domain non-equivalence and temporal mismatch rather than analytical failure (Morawska and Nazaroff, Indoor Air, 2013; Nazaroff, Indoor Air, 2014).

The Core Rule for Mycotoxin Test Selection

Before choosing any test, ask:

What exposure or environmental question am I actually trying to answer

  • If the question is about what people may be breathing, testing must align with the Airborne Domain.
  • If the question is about what has accumulated historically, testing belongs in the Dust Reservoir Domain.
  • If the question is about what remains on a specific material or location, testing belongs in the Surface Domain.
Exposure QuestionAppropriate DomainWhat It Represents
What are occupants breathing?Airborne DomainInhalation-relevant, real-time exposure
What has accumulated over time?Dust Reservoir DomainHistorical deposition
What remains on a surface/material?Surface DomainLocalized material contamination

Selecting a method before defining the question leads to cross-domain misalignment, where results are interpreted beyond the physical and temporal limits of the sampling domain.

Core Rule:

Define the exposure question first. Then select the analytical domain.

Chemical molecular structure versus biological DNA strand comparison illustrating differences in methods used for a mold and mycotoxin test

Step One: Define the Hazard Class

Environmental testing in mold-impacted spaces involves two fundamentally different hazard classes.

Biological Hazards (Mold and Fungal Structures)

These include:

  • Mold spores
  • Hyphal fragments
  • Fungal structures on materials or in dust

These hazards are governed by coarse particle behavior, gravitational settling, and short-term airborne presence.

Biological testing is typically used to answer:

  • Where mold is growing
  • Whether spore levels are elevated relative to outdoors
  • Whether water damage or material contamination is present

These measurements characterize building conditions and biological presence, not inhalation-relevant chemical exposure (Eduard, Annals of Occupational Hygiene, 2006).

Chemical Hazards (Mycotoxins)

Mycotoxins are chemically stable, non-living compounds that can associate with fine and ultrafine particles and persist independently of visible mold or spore abundance (Bennett and Klich, Clinical Microbiology Reviews, 2003).

Chemical hazard questions include:

  • Are mycotoxins present in the breathing zone?
  • Are they associated with particles capable of remaining airborne?
  • Are residues present after cleaning or remediation?

These questions are about exposure-aligned environmental presence, not biological source identification.

CategoryBiological HazardsChemical Hazards (Mycotoxins)
What is measuredSpores, hyphae, fungal structuresMycotoxin compounds
Particle behaviorCoarse particles, gravitational settlingFine and ultrafine particle association
Primary questionWhere mold is growingWhat occupants may be inhaling
RepresentsBuilding condition and biological presenceExposure-aligned environmental presence
Independent of visible mold?NoYes

Hazard class must be defined before selecting a testing domain. Domain choice without hazard classification leads to internally consistent but exposure-misaligned interpretation.

Comparison of airborne exposure, settled dust, and surface testing methods used to evaluate mycotoxins in a home environment.

The Three Analytical Domains Explained

Environmental tests do not measure the same “environment.” They measure different physical phases and time scales of the indoor system.

The Airborne Domain (Exposure-Aligned Testing)

This domain represents suspended particulate matter sampled from the occupied breathing zone over a defined time interval.

Airborne testing is governed by:

  • Fine and ultrafine particle behavior
  • Aerosol transport and suspension time
  • Respiratory deposition probability

This domain is the primary interpretive context for inhalation exposure (Hinds, Aerosol Technology, 1999; Morawska et al., Atmospheric Environment, 1999).

Air testing is most appropriate for questions such as:

  • What is present in the air people are breathing right now
  • Whether airborne mycotoxins are associated with inhalable particle fractions
  • Whether chemical signals persist under occupied conditions

Airborne measurements are time-resolved snapshots, not historical records.

The Dust Reservoir Domain (Historical Context Testing)

This domain represents settled and accumulated material collected from floors, shelves, HVAC filters, and other surfaces over days to months.

Dust testing is governed by:

  • Long-term deposition
  • Cleaning frequency
  • Ventilation patterns
  • Surface adhesion

Dust testing is most appropriate for:

  • Historical contamination patterns
  • Long-term presence indicators
  • Contextual screening

Dust measurements are time-integrated reservoirs, not indicators of what is currently being inhaled (Nazaroff, Indoor Air, 2014).

The Surface Domain (Localized Verification Testing)

This domain represents material present on a specific substrate or location.

Surface testing is used to:

  • Confirm visible or suspected contamination
  • Verify cleaning effectiveness
  • Assess localized residue

Surface results describe one location at one moment, not whole-building or breathing-zone conditions.

Comparison of inhaling airborne mycotoxins in the breathing zone versus settled dust on a shelf, illustrating why an air-based mycotoxin test better reflects inhalation exposure

Why These Domains Are Not Interchangeable

Results from one domain cannot be used as quantitative surrogates for another without explicit empirical linkage between those domains.

A compound detected in dust does not, by itself, establish:

  • Its presence in the air
  • Its persistence in the breathing zone
  • Its inhalation relevance

This principle is known as domain non-equivalence and is a foundational constraint of exposure-aligned interpretation in indoor environmental systems (Morawska and Nazaroff, Indoor Air, 2013; Nazaroff, Indoor Air, 2014).

HVAC Filters and Bulk Filter Sampling

Many practitioners use HVAC filters as “air samples.” Within this framework, they are not.

HVAC filters function as engineered surface reservoirs that integrate particle capture over extended and variable time frames.

Their results are influenced by:

  • Filter efficiency rating
  • System runtime and airflow
  • Bypass leakage and seating
  • Particle size-dependent capture bias

Most residential systems exhibit limited efficiency for fine and ultrafine particles, especially below MERV 13, meaning filters preferentially collect larger particles and underrepresent the particle fractions most relevant to inhalation exposure.

Accordingly, HVAC filter samples belong in the Dust Reservoir Domain, not the Airborne Domain.

They provide historical and contextual information, not time-resolved exposure data from the occupied breathing zone.

Airborne mycotoxins moving through indoor air contrasted with settled dust on a surface, illustrating differences in what a mycotoxin test may measure

Airborne Versus Dust-Based “Mycotoxin Testing”

Some services label dust or surface testing as “airborne mycotoxin testing.”

Within this framework, an airborne measurement is defined by:

  • Collection of suspended particles
  • From the breathing zone
  • Over a defined airflow and time interval

Once particles have settled into dust or onto surfaces, the measurement becomes reservoir-based, regardless of the chemical assay used.

Detecting mycotoxins in dust demonstrates historical or localized chemical presence, not inhalation-relevant airborne burden within the occupied breathing zone during sampling.

The Exposure Alignment Rule

Environmental data must be interpreted within the context of the exposure pathway being evaluated.

Use:

  • Airborne Domain testing for inhalation questions
  • Dust Domain testing for historical presence questions
  • Surface Domain testing for cleaning verification

Inferring exposure from a non-aligned domain introduces temporal mismatch, where historical accumulation is mistaken for current breathing-zone conditions of occupants.

Particle Size and Inhalation Relevance

Particle size governs:

  • Suspension time
  • Transport efficiency
  • Deposition location in the respiratory tract

Coarse particles greater than approximately 2.5 micrometers settle quickly and deposit in the upper airways.

Fine particles between 0.1 and 2.5 micrometers persist longer and penetrate more deeply.

Ultrafine particles smaller than 0.1 micrometers dominate particle number concentration and exhibit high alveolar deposition probability (Hinds, 1999; Morawska et al., 1999; ICRP, 1994).

When mycotoxins associate with these fine and ultrafine fractions, their environmental behavior becomes decoupled from visible mold and spore counts, providing a mechanistic basis for airborne chemical signals in the absence of biological indicators of growth or amplification.

Humidity, Redistribution, and Phase Exchange

Indoor environments continuously exchange material between:

  • Air
  • Surfaces
  • Dust reservoirs

Relative humidity influences hydration layer formation and interfacial partitioning, enabling reversible association of particle-bound compounds rather than permanent chemical transformation (Xu, Journal of Aerosol Science, 2002; Morawska and Nazaroff, 2013).

As humidity and airflow change, mycotoxins can:

  • Deposit onto surfaces
  • Be resuspended
  • Re-enter the air

Observed changes in airborne measurements should therefore be interpreted as redistribution dynamics, not necessarily as source removal or chemical destruction of the contaminant.

Close-up of a mycotoxin particle surrounded by water droplets illustrating how evaporation can lift contaminants into the air during indoor exposure, relevant to an air-based mycotoxin test

Microenvironments and Sampling Location

Indoor air is not uniformly mixed.

Bedrooms, closets, and low-mixing zones can exhibit localized persistence of fine and ultrafine particles, even when whole-building ventilation is active (Thatcher and Layton, Atmospheric Environment, 1995; Nazaroff and Klepeis, Atmospheric Environment, 2004).

Because occupancy often coincides with these zones, sampling location and breathing-zone placement materially influence exposure-aligned interpretation and measurement representativeness.

A Simple Decision Framework

Use this sequence:

  1. Specify the hazard class
    Biological or chemical
  2. Define the environmental question
    Source, history, or inhalation exposure
  3. Select the analytical domain
    Air, dust, or surface
  4. Use cross-domain comparison only as context
    Not as confirmation or substitution

Agreement across domains strengthens interpretation.
Divergence highlights temporal and physicochemical differences, not analytical failure or laboratory error.

Relationship to the Scientific Framework

This guide is a plain-language interpretation of the Part B scientific preprint, which formalizes:

  • Hazard class as a precondition for analytical domain selection
  • Domain non-equivalence across air, dust, and surface measurements
  • Temporal mismatch constraints between snapshot and time-integrated sampling
  • Exposure alignment as the governing interpretive rule
  • Cross-domain comparison as contextual consistency rather than confirmation

For formal definitions, figures, and scientific references, consult the Part B Scientific Preprint at:
/preprints/2026b-exposure-aligned-analytical-domain-framework/ (full manuscript).

Final Takeaway

Choosing the right test begins with choosing the right question.

If you are concerned about what people may be breathing, select an airborne, exposure-aligned method.

If you are concerned about what has accumulated historically, select a dust-based method.

If you are verifying cleaning or material condition, select a surface-based method.

Different tests answer different questions. Using them interchangeably creates confusion and can lead to exposure-misaligned interpretation.

Key Principle

Choose the test that aligns with the exposure question being asked.

You Do Not Have to Figure This Out Alone

If you are unsure which testing approach aligns with your situation, we offer a brief consultation to help homeowners and professionals clarify their environmental question and testing pathway.

This discussion is informational only and does not provide medical, legal, or regulatory advice.

Schedule a 15-Minute Testing Consultation

References and Scientific Basis

This guide is grounded in the Part B scientific preprint and established literature in aerosol physics, exposure science, and mycotoxin research. Outbound links are provided for transparency and academic verification.

  • Ritacco, M. (2026). An Exposure-Aligned Analytical Domain Framework for Interpreting Mycotoxin Measurements Across Airborne, Dust, and Surface Media in Indoor Environments. Respirare Labs Preprint Archive. Internal Preprint Link
  • Morawska, L., & Nazaroff, W. W. (2013). The evolution of indoor particle research. Indoor Air, 23(6), 442–454.
  • Nazaroff, W. W. (2004). Indoor particle dynamics. Indoor Air, 14(Suppl 7), 175–183. https://pubmed.ncbi.nlm.nih.gov/15330785/
  • Hinds, W. C. (1999). Aerosol Technology: Properties, Behavior, and Measurement of Airborne Particles. Wiley.
  • Bennett, J. W., & Klich, M. (2003). Mycotoxins. Clinical Microbiology Reviews, 16(3), 497–516. https://pmc.ncbi.nlm.nih.gov/articles/PMC164220/
  • Thatcher, T. L., & Layton, D. W. (1995). Deposition, resuspension, and penetration of particles within a residence. Atmospheric Environment, 29(13), 1487–1497. https://www.sciencedirect.com/science/article/abs/pii/135223109500016R
  • Xu, Y. (2002). Effects of humidity and ventilation on interactions of volatile compounds with indoor materials. Journal of Aerosol Science, 33(3), 493–503. https://www.sciencedirect.com/science/article/pii/S0021850201001756
  • International Commission on Radiological Protection. (1994). Human Respiratory Tract Model for Radiological Protection (ICRP Publication 66). Annals of the ICRP, 24(1–3).
Share this interpretive guide

About this Guide

This guide interprets Respirare Labs’ 2026 Part B preprint on exposure-aligned analytical domain selection for indoor mycotoxin testing. 

Read the full preprint →

Table of Contents